HER2-mutated colorectal cancers show distinct genomic features from HER2-amplified tumors

◇ RESEARCH

Analysis of 4,348 CRC patients found that ERBB2/HER2 mutations occurred in 2.2% and amplifications in 2.0%, with distinct genomic landscapes and clinical characteristics between the two groups. (Oncologist)